Eprofil
Brand names,
Eprofil
Analogs
Eprofil
Brand Names Mixture
Eprofil
Chemical_Formula
C11H16N2O
Eprofil
RX_link
http://www.rxlist.com/cgi/generic3/tocainide.htm
Eprofil
fda sheet
Eprofil
msds (material safety sheet)
Eprofil
Synthesis Reference
No information avaliable
Eprofil
Molecular Weight
192.258 g/mol
Eprofil
Melting Point
246-266 oC
Eprofil
H2O Solubility
1.07E+004 mg/L
Eprofil
State
Solid
Eprofil
LogP
1.308
Eprofil
Dosage Forms
400 mg and 600 mg tablets for oral administration
Eprofil
Indication
For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening.
Eprofil
Pharmacology
Tocainide is a primary amine analog of lidocaine with antiarrhythmic properties useful in the treatment of ventricular arrhythmias. Tocainide, like lidocaine, produces dose dependent decreases in sodium and potassium conductance, thereby decreasing the excitability of myocardial cells. In experimental animal models, the dose-related depression of sodium current is more pronounced in ischemic tissue than in normal tissue. Tocainide is a Class I antiarrhythmic compound with electrophysiologic properties in man similar to those of lidocaine, but dissimilar from quinidine, procainamide, and disopyramide.
Eprofil
Absorption
Following oral administration, the bioavailability approaches 100 percent, and is unaffected by food.
Eprofil
side effects and Toxicity
The oral LD50 of tocainide was calculated to be about 800 mg/kg in mice, 1000 mg/kg in rats, and 230 mg/kg in guinea pigs; deaths were usually preceded by convulsions.
Eprofil
Patient Information
Eprofil
Organisms Affected
Humans and other mammals